Skip to main content

Latest Articles

Latest Articles

Showing 9 / 934 GLP-1 Medications articles

Individuals Stopping GLP-1 Medications Encounter Abrupt and Intense Hunger
Health

Individuals Stopping GLP-1 Medications Encounter Abrupt and Intense Hunger

GLP-1 receptor agonists, such as Wegovy and Ozempic, offer significant weight loss and health benefits but stopping them can lead to quick weight regain and rebound hunger. A University of Oxford study reveals that users often return to pre-treatment weights within 1.7 years, with health markers bouncing back even faster. Experts stress the need for comprehensive long-term strategies to manage obesity effectively.

Shotlee··3 min read
2026 Signals the Era of Obesity Pills: Uncovering Their Role in Transforming the GLP-1 Market
Health

2026 Signals the Era of Obesity Pills: Uncovering Their Role in Transforming the GLP-1 Market

The year 2026 heralds a shift in obesity treatment with the arrival of GLP-1 pills from Novo Nordisk and Eli Lilly, offering potential alternatives to injections. These oral options promise greater convenience and affordability, possibly attracting new patients to weight loss therapies. Experts highlight their role in expanding the market while maintaining similar efficacy.

Shotlee··2 min read
Tucker Carlson Is Showing Signs Of An 'Ozempic Face' Emerging, And People Are Taking Notice
Celebrity Health

Tucker Carlson Is Showing Signs Of An 'Ozempic Face' Emerging, And People Are Taking Notice

Florida Republican gubernatorial candidate James Fishback shared a photo on X of himself with Tucker Carlson, prompting discussions about the pundit's rapid weight loss and potential use of weight-loss medications. Social media users noted Carlson's hollowed cheeks, sunken eyes, and saggy skin, resembling the 'Ozempic face' phenomenon. Concerns about his health also arose amid speculation.

Shotlee··2 min read
Elderly Americans Abandon Weight-Loss Medications in Droves
Health

Elderly Americans Abandon Weight-Loss Medications in Droves

Senior citizens in the U.S. often discontinue highly effective weight-loss medications such as GLP-1 drugs shortly after starting them, resulting in regained pounds and diminished health advantages. Side effects, high expenses, and inadequate insurance coverage frequently play key roles in this trend. Experts advocate for better coverage and ongoing research to address these challenges for older populations.

Shotlee··5 min read
Returning to Baseline in 2 Years: Individuals Regain Weight More Quickly After Halting Obesity Medications Than Following a Diet
Health

Returning to Baseline in 2 Years: Individuals Regain Weight More Quickly After Halting Obesity Medications Than Following a Diet

A University of Oxford study indicates that weight loss from medications like GLP-1 drugs often rebounds quickly upon cessation, faster than after dieting and exercise. Behavioral programs lead to slower regain, emphasizing sustainable lifestyle changes. Obesity impacts billions globally, raising risks for heart disease and diabetes.

Shotlee··2 min read